Methacholine Challenge Test: Indications, Contraindications, Procedure, and Interpretation

Indications

• The American Thoracic Society (ATS) strongly recommends a methacholine challenge for patients ≥ 6 years with suspected asthma and normal baseline spirometry to confirm or exclude the diagnosis (strong recommendation). 1
• The test provides a high negative predictive value; a negative result makes asthma unlikely. 3
• The European Respiratory Society (ERS) pediatric guideline advises methacholine challenge when first‑line objective tests (spirometry, bronchodilator response, FeNO) are nondiagnostic. 2

Absolute Contraindications

• Baseline FEV₁ < 60 % predicted (or < 1.5 L in adults) – test must not be performed. 1
• Recent (≤ 3 months) myocardial infarction or stroke. 1
• Unstable angina, uncontrolled arrhythmias, or symptomatic severe aortic stenosis. 1
• Uncontrolled heart failure or acute pulmonary embolism. 1
• Known aortic aneurysm or suspected dissecting aneurysm. 1

Relative Contraindications (require careful consideration)

• Baseline FEV₁ 60‑70 % predicted – test may proceed with close observation and adequate preparation. 1
• Ongoing asthma exacerbation or clinically apparent wheezing – consider postponing the test. 1

Pre‑Test Preparation

Medication Withholding (to avoid false‑negative results)

• Short‑acting β₂‑agonists: withhold 8 h. 1
• Long‑acting β₂‑agonists: withhold 48 h. 1
• Theophylline: withhold 24‑48 h. 1
• Anticholinergics: withhold 24 h. 1

Baseline Spirometry Requirements

• Baseline FEV₁ must be ≥ 60 % predicted and ≥ 1.5 L in adults. 1
• Obtain at least two acceptable FEV₁ values that agree within 0.10‑0.20 L to ensure quality. [5][6]

Test Performance

Dosing Protocols (ATS‑endorsed)

• 5‑Breath Dosimeter Method – inhalation of five breaths of increasing methacholine concentrations (0.0625, 0.25, 1.0, 4.0, 16.0 mg/mL). 1
• 2‑Minute Tidal Breathing Method – normal tidal breathing through nebulizer for 2 min at each concentration, using the same concentration progression. 1

Procedural Steps (key points)

• Perform baseline spirometry with ≥ 3 acceptable FEV₁ maneuvers and record the highest value. [5][6]
• Administer a saline (diluent) inhalation; a ≥ 20 % fall in FEV₁ after diluent alone is considered a positive test. 1
• Incrementally increase methacholine concentration, measuring FEV₁ 30 s and 90 s after each dose. Stop when FEV₁ falls ≥ 20 % or the maximum concentration is reached. 1
• After a positive threshold is reached, give 200‑400 µg albuterol and confirm FEV₁ recovery to within 10 % of baseline before discharge. 1

Result Interpretation

Positive Test Definition

• A ≥ 20 % reduction in FEV₁ from the post‑diluent baseline defines a positive methacholine challenge. [1][7]

Provocative Concentration (PC₂₀) and Severity Grading (ATS)

• These PC₂₀ thresholds are endorsed by the ATS. 7

Pediatric Threshold (ERS)

• For children, the ERS pediatric guideline uses PC₂₀ ≤ 8 mg/mL as the positive threshold. 2

Clinical Context for Positive Results

• A positive test does not automatically confirm asthma; interpretation must consider pre‑test probability, presence of allergic rhinitis, COPD, or other conditions that can cause airway hyperresponsiveness. [7][1]

Clinical Context for Negative Results

• A negative test (PC₂₀ > 16 mg/mL) does not exclude asthma, especially in patients with high clinical suspicion or those with exercise‑induced/occupational asthma. 7

Safety Considerations

Emergency Equipment (ATS requirement)

• Immediate availability of rapid‑acting inhaled bronchodilators (albuterol, ipratropium).
• Supplemental oxygen supply.
• Small‑volume nebulizer.
• Pulse oximeter and blood‑pressure monitor. 1

Adverse Events

• Transient cough, wheezing, dyspnea, and chest tightness occur in 20‑25 % of patients undergoing the test. 1

Technician Safety

• Testing rooms must have adequate ventilation to minimize aerosol exposure. 1

Common Pitfalls (ATS guidance)

• Performing the test with baseline FEV₁ < 60 % predicted increases risk without diagnostic benefit. 1
• Failure to withhold bronchodilators for the recommended intervals leads to false‑negative results. 1
• Accepting poor‑quality spirometry maneuvers yields unreliable FEV₁ measurements. [5][6]
• Interpreting a positive methacholine challenge as definitive asthma without evaluating alternative causes may result in misdiagnosis. 7